{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:37:49Z","timestamp":1792654669522,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1995,12,1]],"date-time":"1995-12-01T00:00:00Z","timestamp":817776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1038\/nm1295-1297","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:03:24Z","timestamp":1092877404000},"page":"1297-1302","source":"Crossref","is-referenced-by-count":785,"title":["Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity"],"prefix":"10.1038","volume":"1","author":[{"given":"J.I.","family":"Mayordomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Storkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Celluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.D.","family":"Falo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Melief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"Ildstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Martin Kast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Deleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm12951297_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/369357a0","volume":"369","author":"D Pardoll","year":"1994","unstructured":"Pardoll, D. Tumour antigens: A new look for the 1990s. Nature 369, 357\u2013358 (1994).","journal-title":"Nature"},{"key":"BFnm12951297_CR2","first-page":"116","volume":"16","author":"S Grabbe","year":"1995","unstructured":"Grabbe, S., Beissert, S., Schwartz, T. & Granstein, R.D. Dendritic ceils as initiators of tumor immune responses: A possible strategy for tumor immunotherapy? Immun. Today 16, 116\u2013120 (1995).","journal-title":"Immun. Today"},{"key":"BFnm12951297_CR3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4049\/jimmunol.123.2.784","volume":"123","author":"K Tamaki","year":"1979","unstructured":"Tamaki, K., Stingl, G., Gullino, M., Sachs, D.H. & Katz, S.I. Ia antigens in mouse skin are predominantly expressed on Langerhans cells. J. Immun. 123, 784\u2013787 (1979).","journal-title":"J. Immun."},{"key":"BFnm12951297_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/eji.1830240405","volume":"24","author":"Z Razi-Wolf","year":"1994","unstructured":"Razi-Wolf, Z., Falo, L.D. & Reiser, H. Expression and function of the costimulatory molecule B7 on murine Langerhans cells: Evidence for an alternative CTLA-4 ligand. Eur. J. Immun. 24, 805\u2013811 (1994).","journal-title":"Eur. J. Immun."},{"key":"BFnm12951297_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1084\/jem.175.5.1157","volume":"175","author":"K Inaba","year":"1992","unstructured":"Inaba, K. et al. Identification of proliferating dendritic cell progenitors in mouse blood. J. exp. Med. 175, 1157\u20131167 (1992).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","volume":"176","author":"K Inaba","year":"1992","unstructured":"Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor. J. exp. Med. 176, 1693\u20131702 (1992).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/360258a0","volume":"360","author":"C Caux","year":"1992","unstructured":"Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature 360, 258\u2013261 (1992).","journal-title":"Nature"},{"key":"BFnm12951297_CR8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V78.3.635.635","volume":"78","author":"C Caux","year":"1991","unstructured":"Caux, C. et al. Potentiation of early hematopoiesis by TNF alpha is followed by inhibition of granulopoietic differentiation and proliferation. Blood 78, 635\u2013644 (1991).","journal-title":"Blood"},{"key":"BFnm12951297_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1084\/jem.171.1.159","volume":"171","author":"F Koch","year":"1990","unstructured":"Koch, F. et al. Tumor necrosis factor a maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte\/macrophage colony-stimulating factor, without inducing their functional maturation. J. exp. Med. 171, 159\u2013171 (1990).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.180.1.83","volume":"180","author":"N Romani","year":"1994","unstructured":"Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. exp. Med. 180, 83\u201393 (1994).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J. exp. Med. 179, 1109\u20131118 (1994).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00002371-199410000-00061","volume":"16","author":"T Zorina","year":"1994","unstructured":"Zorina, T. et al. Culture of dendritic cells from murine bone marrow supplemented with GM-CSF and TNF-alpha. J. Immunother. 16, 247 (1994).","journal-title":"J. Immunother."},{"key":"BFnm12951297_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.154.1.97","volume":"154","author":"LL Lanier","year":"1995","unstructured":"Lanier, L.L. et al. CD80(B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immun. 154, 97\u2013105 (1995).","journal-title":"J. Immun."},{"key":"BFnm12951297_CR14","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1084\/jem.180.5.1841","volume":"180","author":"C Caux","year":"1994","unstructured":"Caux, C. et al. B70\/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. exp. Med. 180, 1841\u20131847 (1994).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/369067a0","volume":"369","author":"O Mandelboim","year":"1994","unstructured":"Mandelboim, O. et al. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369, 67\u201371 (1994).","journal-title":"Nature"},{"key":"BFnm12951297_CR16","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/eji.1830230929","volume":"23","author":"MCW Feltkamp","year":"1993","unstructured":"Feltkamp, M.C.W. et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immun. 23, 2242\u20132249 (1993).","journal-title":"Eur. J. Immun."},{"key":"BFnm12951297_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/351290a0","volume":"351","author":"K Falk","year":"1991","unstructured":"Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. & Rammensee, H.-G. Allele-specific models revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290\u2013296 (1991).","journal-title":"Nature"},{"key":"BFnm12951297_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nm0795-649","volume":"1","author":"LD Falo","year":"1995","unstructured":"Falo, L.D., Kovacsovics-Bankowski, M., Thompson, K. & Rock, K.L. Targeting antigen into the phagocytic pathway In vivo induces protective tumour immunity. Nature Med. 1, 649\u2013653 (1995).","journal-title":"Nature Med."},{"key":"BFnm12951297_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1084\/jem.182.1.255","volume":"182","author":"A Porgador","year":"1995","unstructured":"Porgador, A. & Gilboa, E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. exp. Med. 182, 255\u2013260 (1995).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/bjc.1987.4","volume":"55","author":"LA Gyure","year":"1987","unstructured":"Gyure, L.A., Barfoot, R., Denham, S. & Hall, J.G. Immunity to a syngeneic sarcoma induced in rats by syngeneic lymph cells exposed to the tumour either in vivo or in vitro. Br. J. Cancer 55, 17\u201320 (1987).","journal-title":"Br. J. Cancer"},{"key":"BFnm12951297_CR21","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1073\/pnas.82.13.4495","volume":"82","author":"SC Knight","year":"1985","unstructured":"Knight, S.C., Hunt, R., Dote, C. & Medawar, P.B. Influence of dendritic cells on tumor growth. Proc. natn. Acad. Sci. U.S.A. 82, 4495\u20134497 (1985).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm12951297_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0167-5699(95)80061-1","volume":"16","author":"C Caux","year":"1995","unstructured":"Caux, C., Liu, Y-L. & Banchereau, J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immun. Today 16, 2\u20134 (1995).","journal-title":"Immun. Today"},{"key":"BFnm12951297_CR23","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.4049\/jimmunol.146.10.3656","volume":"146","author":"S Grabbe","year":"1991","unstructured":"Grabbe, S. et al. Tumor antigen presentation by murine epidermal cells. J. Immun. 146, 3656\u20133661 (1991).","journal-title":"J. Immun."},{"key":"BFnm12951297_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/eji.1830240317","volume":"24","author":"V Flamand","year":"1994","unstructured":"Flamand, V. et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immun. 24, 605\u2013610 (1994).","journal-title":"Eur. J. Immun."},{"key":"BFnm12951297_CR25","first-page":"520a","volume":"84","author":"FJ Hsu","year":"1994","unstructured":"Hsu, F.J. et al. Antigen-pulsed dendritic cells are effective in inducing immune responses in patients with B-cell lymphoma. Blood 84, 520a (1994).","journal-title":"Blood"},{"key":"BFnm12951297_CR26","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.140.9.3186","volume":"140","author":"WM Kast","year":"1988","unstructured":"Kast, W.M., Boog, C.J.P., Roerp, B.O., Voordouw, A.C. & Melief, C.J.P. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. J. Immun. 140, 3186\u20133193 (1988).","journal-title":"J. Immun."},{"key":"BFnm12951297_CR27","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1126\/science.1465616","volume":"258","author":"H Mizoguchi","year":"1992","unstructured":"Mizoguchi, H. et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258, 1795\u20131798 (1992).","journal-title":"Science"},{"key":"BFnm12951297_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nm0595-471","volume":"1","author":"Z-K Pan","year":"1995","unstructured":"Pan, Z.-K., Ikonomidis, G., Lazenby, A., Pardoll, D. & Paterson, Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nature Med. 1, 471\u2013477 (1995).","journal-title":"Nature Med."},{"key":"BFnm12951297_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1084\/jem.182.1.261","volume":"182","author":"P Aichele","year":"1995","unstructured":"Aichele, P., Brduscha-Riem, K., Zinkernagel, R.M., Hengartner, H. & Pircher, H. T cell priming versus T cell tolerance induced by synthetic peptides. J. exp. Med. 182, 261\u2013266 (1995).","journal-title":"J. exp. Med."},{"key":"BFnm12951297_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/1074-7613(94)90086-8","volume":"1","author":"MK Jenkins","year":"1994","unstructured":"Jenkins, M.K. The ups and downs of T cell costimulation. Immunity 1, 443\u2013446 (1994).","journal-title":"Immunity"},{"key":"BFnm12951297_CR31","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1002\/eji.1830241118","volume":"24","author":"M Bellone","year":"1994","unstructured":"Bellone, M. et al. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur. J. Immun. 24, 2691\u20132698 (1994).","journal-title":"Eur. J. Immun."},{"key":"BFnm12951297_CR32","first-page":"124","volume":"55","author":"MA Frassanito","year":"1995","unstructured":"Frassanito, M.A. et al. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte. Cancer Res. 55, 124\u2013128 (1995).","journal-title":"Cancer Res."},{"key":"BFnm12951297_CR33","first-page":"64","volume-title":"Biologic Therapy of Cancer","author":"WJ Storkus","year":"1995","unstructured":"Storkus, W.J. & Lotze, M.T. Biology of tumor antigens: Tumor antigens recognized by immune cells. In: Biologic Therapy of Cancer, 2nd edn (eds DeVita, V. T., Hellman, S. & Rosenberg, S.A.) 64\u201377 (Lippincott, Philadelphia, 1995)."},{"key":"BFnm12951297_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1073\/pnas.92.2.432","volume":"92","author":"GE Peoples","year":"1995","unstructured":"Peoples, G.E. et al. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2\/neu-derived peptide. Proc. natn. Acad. Sci. U.S.A. 92, 432\u2013436 (1995).","journal-title":"Proc. natn. Acad. Sci. U.S.A."},{"key":"BFnm12951297_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch, F.X. et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. natn. Cancer Inst. 87, 796\u2013802 (1995).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm12951297_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0092-8674(88)91043-4","volume":"54","author":"MW Moore","year":"1988","unstructured":"Moore, M.W., Carbone, F.R. & Bevan, M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777\u2013785 (1988).","journal-title":"Cell"},{"key":"BFnm12951297_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/intimm\/5.8.849","volume":"5","author":"H Takahashi","year":"1993","unstructured":"Takahashi, H., Nakagawa, Y., Yokomuro, K. & Berzofsky, J.A. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immun. 5, 849\u2013857 (1993).","journal-title":"Int. Immun."},{"key":"BFnm12951297_CR38","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4049\/jimmunol.150.4.1244","volume":"150","author":"KL Rock","year":"1993","unstructured":"Rock, K.L., Fleischacker, C. & Gamble, S. Peptide-priming of cytolytic T cell immunity in vivo using (\u03b22-microglobulin as an adjuvant. J. Immun. 150, 1244\u20131252 (1993).","journal-title":"J. Immun."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1295-1297","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1295-1297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1295-1297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:22:55Z","timestamp":1684448575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1295-1297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["BFnm12951297"],"URL":"https:\/\/doi.org\/10.1038\/nm1295-1297","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}